Massimo E. Masserini
Monza, 20900, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Understanding Aβ Peptide Binding to Lipid Membranes: A Biophysical Perspective.
Journal: International journal of molecular sciences
Published: April 27, 2024
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity.
Journal: Annals of medicine
Published: May 05, 2023
Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response.
Journal: Neuro-oncology advances
Published: August 11, 2021
The interaction of Aβ42 peptide in monomer, oligomer or fibril forms with sphingomyelin/cholesterol/ganglioside bilayers.
Journal: International journal of biological macromolecules
Published: August 12, 2020
β-Amyloid (1-42) peptide adsorbs but does not insert into ganglioside-containing phospholipid membranes in the liquid-disordered state: modelling and experimental studies.
Journal: International journal of biological macromolecules
Published: April 16, 2020
The Binding of Aβ42 Peptide Monomers to Sphingomyelin/Cholesterol/Ganglioside Bilayers Assayed by Density Gradient Ultracentrifugation.
Journal: International journal of molecular sciences
Published: February 08, 2020
Nanomedicine for the Treatment of Alzheimer's Disease.
Journal: Journal of biomedical nanotechnology
Published: August 30, 2019
Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: March 18, 2019
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for the treatment of Alzheimer's disease.
Journal: International journal of nanomedicine
Published: July 24, 2018
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier.
Journal: ACS nano
Published: June 29, 2018
The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state.
Journal: Nanomedicine (London, England)
Published: January 30, 2018
Last Updated: 09/26/2026